Aptose Biosciences Inc. has entered into an agreement to sell up to $25 million in common shares to an equity investor, with specific conditions and limitations on the sale and issuance of shares over a 24-month period. The company will also issue 240,604 shares as part of the agreement and expects to use the proceeds for working capital and general corporate purposes.